Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 87

Sort by

Sort Order Select

Journal Articles

Thrombophilia Testing in Hospitalized Patients with Acute Ischemic Stroke: An Opportunity for Hematology Input

Jori May, MD, Chen Lin, MD, Kimberly Martin, PhD, Laura J Taylor, M.T., Radhika Gangaraju, MD

Blood (2019) 134 (Supplement_1): 2105.

https://doi.org/10.1182/blood-2019-122615

Published: 2019

Journal Articles

Risk Factors, Clinical Manifestations, Treatment Duration and Outcomes in Carriers of Severe Inherited Thrombophilias

Ivan Bascon, Molecular Bioscience and Biotechnology, B.S., Paul J Christos, Dr.P.H., M.S., Maria Teresa De Sancho, MD MSc

Blood (2019) 134 (Supplement_1): 3657.

https://doi.org/10.1182/blood-2019-132248

Published: 2019

Journal Articles

Approaching Venous Thromboembolism Disease (DVT) from Another Perspective: Better Management in a Multidisciplinary DVT Unit Improves Clinical Outcomes and Post Thrombotic Syndrome. One-Year Experience in Our Hospital

Milagros Suito, MD, Maria Cerdá, MD, Olga Benítez, MD, Alba Cabirta, MD, Francesc Bosch, MD PhD, Amparo Santamaria, MD PhD

Blood (2019) 134 (Supplement_1): 2431.

https://doi.org/10.1182/blood-2019-131327

Published: 2019

Journal Articles

One- Week Prophylaxis with Enoxaparin after Hospital Discharge Is Effective in Preventing Venous Thromboembolism in Living Liver Donors- Single Institution Retrospective Analysis

Leila Khaddour, MD, Zaid Al Saheli, MD, Yaser Alkhatib, MD, Marwan Abouljoud, MD, Philip Kuriakose, MD

Blood (2019) 134 (Supplement_1): 2442.

https://doi.org/10.1182/blood-2019-124169

Published: 2019

Journal Articles

A Pilot Study of an Oral Anticoagulant, Apixaban, in Secondary Prophylaxis of Venous Thromboembolism (VTE) in Children and Adolescents

Ashley Pinchinat, MD, Neida Otero, Harshini Mahanti, BS, MSCR, Erin Morris, RN, BSN, Adele Brudnicki, MD, Deborah Friedman, MD, Simon Li, MD, Oya Levendoglu-Tugal, MD, Mitchell S Cairo, MD

Blood (2019) 134 (Supplement_1): 2443.

https://doi.org/10.1182/blood-2019-130468

Published: 2019

Journal Articles

Prothrombin R541W Mutation Impairs Protein C Activation and Constitutes a New Genetic Risk Factor for Venous Thrombosis

XI WU, M.S., Dai Jing, Fang Li, PhD, Qin Xu, PhD, Changming Chen, Qiulan Ding, Xuefeng Wang, MD, Wenman WU, MD

Blood (2019) 134 (Supplement_1): 442.

https://doi.org/10.1182/blood-2019-127694

Published: 2019

Journal Articles

Facing Deep Venous Thrombosis (DVT) in University Tertiary Hospital: Role of Conventional Thrombophilia Testing in Idiopathic DVT Treatment

Milagros Suito, MD, Maria Cerdá, MD, Olga Benítez, MD, Alba Cabirta, MD, Francesc Bosch, MD PhD, Amparo Santamaria, MD PhD

Blood (2019) 134 (Supplement_1): 4958.

https://doi.org/10.1182/blood-2019-132042

Published: 2019

Journal Articles

Assessment and Reduction of Unnecessary Thrombophilia Testing in Patients 18-60 Years with Acute Cryptogenic Ischemic Stroke

Effrosyni Apostolidou, MD, PhD, Masumeh Hatami, MD, Sean.I. Savitz, MD, Eric Thomas, MD, Priya Khatri, MBA, MPH, Alicia Zha, MD

Blood (2019) 134 (Supplement_1): 3397.

https://doi.org/10.1182/blood-2019-124521

Published: 2019

Journal Articles

Neurological Manifestations Due to Extramedullary Hematopoiesis in Greek Patients with Thalassemia Intermedia: Not Such a Rare Clinical Finding

Michael D. Diamantidis, MD PhD MSc, Alexandra Kourakli, MD PhD, Efthymia Vlachaki, MBBS, Despoina Pantelidou, MD PhD, Evgenia Verigou, Evangelos Alexiou, Fotios Girtovitis, PhD MD, Paraskevi Fotiou, Elisavet Grouzi, Argiris Symeonidis, MD PhD

Blood (2018) 132 (Supplement 1): 2349.

https://doi.org/10.1182/blood-2018-99-119376

Published: 2018

Journal Articles

Lipoprotein(a) a Risk Factor for Venous Thrombosis and Pulmonary Embolism in Patients Younger Than 50 Years of Age

Sonha Nguyen, MD, Lynette Ilano, MD, Nneka Oluoha, MD, Zahra Pakbaz, MD

Blood (2018) 132 (Supplement 1): 5055.

https://doi.org/10.1182/blood-2018-99-113975

Published: 2018

Journal Articles

Compound Homozygous Factor V Leiden and Heterozygous Prothrombin Gene Mutation: The First Report in a Pregnant African with Extensive Thrombosis

Livingstone Gayus Dogara, MBBS, FMCPath, Joseph Ogirima Ovosi, MBBS, MSc, FMCP (Clinical Pharmacology), Caleb Mohammed, MBBS, FWACS, Bilkisu Farouk, MBBS, FWACS, Ziphozonke Mafika, MBBCH, MMed, FCPath, Johnny Mahlangu

Blood (2018) 132 (Supplement 1): 5056.

https://doi.org/10.1182/blood-2018-99-114865

Published: 2018

Journal Articles

Coagulation Profile of Sickle Cell Patients with Leg Ulcers

Ugochi Olivia Ogu, MD, Ashley Buscetta, MSN, FNP-BC, CWOCN, Elena Crouch, Shuo You, MD, Christopher Bradford, BA, Moonseong Heo, PhD, Khadijah Abdallah, MPH, Giacomo Vinces, D.O., Vence L. Bonham, J.D., Caterina Minniti, MD

Blood (2018) 132 (Supplement 1): 2380.

https://doi.org/10.1182/blood-2018-99-113184

Published: 2018

Journal Articles

To Test or Not to Test? Quantifying and Reducing Inappropriate Hypercoagulable Workups in the Inpatient Setting

Mariola Vazquez-Martinez, MD, Erika Correa, MD MS, Shaun Hanson, MD, Kathleen Degen, MD, Kevin D'Mello, MD, Kristine Ward, MD, Michael Styler, MD

Blood (2018) 132 (Supplement 1): 5819.

https://doi.org/10.1182/blood-2018-99-117183

Published: 2018

Journal Articles

Outcomes and Risk Factors Associated with Thrombosis Recurrence and Post-Thrombotic Syndrome in Children and Adolescents with May-Thurner Syndrome

Michael H. White, MD, Brandon M. Cramer, MD, Anne E. Gill, MD, C. Matthew Hawkins, MD, Kavita N. Patel, MD MS

Blood (2017) 130 (Supplement 1): 3417.

https://doi.org/10.1182/blood.V130.Suppl_1.3417.3417

Published: 2017

Journal Articles

Using Electronic Best Practice Alerts to Improve Thrombophilia Testing Based on ASH Choosing Wisely Guidelines

Tomi Jun, MD, Henry Kwang, MD, Eric Mou, MD, Caroline Berube, MD, Neil Shah, MD, Rajani Kaimal, MS, Jason Bentley, PhD, Neera Ahuja, MD, Lisa Shieh, MD, Jason Hom, MD

Blood (2017) 130 (Supplement 1): 3355.

https://doi.org/10.1182/blood.V130.Suppl_1.3355.3355

Published: 2017

Journal Articles

Referral for Thrombophilia Testing in an Obstetric Patient Population: A Tertiary Centre Experience

Ayesha Ejaz, Helen Moore

Blood (2017) 130 (Supplement 1): 5597.

https://doi.org/10.1182/blood.V130.Suppl_1.5597.5597

Published: 2017

Journal Articles

Use of Direct Oral Anticoagulants in Inherited Thrombophilia

Puja Arora, MD, Surabhi Palkimas, PharmD, Margaret Kim, Laura Talamo, MD, Hillary S. Maitland, MDMS

Blood (2017) 130 (Supplement 1): 3724.

https://doi.org/10.1182/blood.V130.Suppl_1.3724.3724

Published: 2017

Journal Articles

Levels of Protein S and Risk of Thromboembolism

Samip R Master, MD, John Hedgepeth, McLarty Jerry, Richard Preston Mansour, MD

Blood (2017) 130 (Supplement 1): 4899.

https://doi.org/10.1182/blood.V130.Suppl_1.4899.4899

Published: 2017

Journal Articles

Efficacy of Direct Oral Anticoagulants (DOAC) in Patients with Antiphospholipid Antibody Syndrome (APS)

Krishna Gundabolu, MBBS, Vijaya R. Bhatt, MBBS, Matthew A. Lunning, DO, Muhamed Baljevic, MD

Blood (2017) 130 (Supplement 1): 4917.

https://doi.org/10.1182/blood.V130.Suppl_1.4917.4917

Published: 2017

Journal Articles

Final Results from the Phase 3 Traial Areta Comparing a Novel, Extended-Release Anagrelide Formulation to Placebo in Essential Thrombocythemia Patients with Defined Risk Status

Heinz Gisslinger, MD, Christoph Klade, Kudrat Abdulkadyrov, MD, Slawomira Kyrcz-Krzemien, MD PhD, Elena Karyagina, MD, Anait L. Melikyan, MD PhD, Krzysztof Warzocha, Barbara Grohmann-Izay, MD, Juri Hodisch, MD, Rudolf S. Widmann, PhD BSc, Robert Kralovics, Petro E. Petrides, MD PhD, Jiri Schwarz, MD PhD, Jean-Jacques Kiladjian, MD PhD

Blood (2016) 128 (22): 476.

https://doi.org/10.1182/blood.V128.22.476.476

Published: 2016

NARROW

Thrombophilia Testing in Hospitalized Patients with Acute Ischemic Stroke: An Opportunity for Hematology Input

Risk Factors, Clinical Manifestations, Treatment Duration and Outcomes in Carriers of Severe Inherited Thrombophilias

Approaching Venous Thromboembolism Disease (DVT) from Another Perspective: Better Management in a Multidisciplinary DVT Unit Improves Clinical Outcomes and Post Thrombotic Syndrome. One-Year Experience in Our Hospital

One- Week Prophylaxis with Enoxaparin after Hospital Discharge Is Effective in Preventing Venous Thromboembolism in Living Liver Donors- Single Institution Retrospective Analysis

A Pilot Study of an Oral Anticoagulant, Apixaban, in Secondary Prophylaxis of Venous Thromboembolism (VTE) in Children and Adolescents

Prothrombin R541W Mutation Impairs Protein C Activation and Constitutes a New Genetic Risk Factor for Venous Thrombosis

Facing Deep Venous Thrombosis (DVT) in University Tertiary Hospital: Role of Conventional Thrombophilia Testing in Idiopathic DVT Treatment

Assessment and Reduction of Unnecessary Thrombophilia Testing in Patients 18-60 Years with Acute Cryptogenic Ischemic Stroke

Neurological Manifestations Due to Extramedullary Hematopoiesis in Greek Patients with Thalassemia Intermedia: Not Such a Rare Clinical Finding

Lipoprotein(a) a Risk Factor for Venous Thrombosis and Pulmonary Embolism in Patients Younger Than 50 Years of Age

Compound Homozygous Factor V Leiden and Heterozygous Prothrombin Gene Mutation: The First Report in a Pregnant African with Extensive Thrombosis

Coagulation Profile of Sickle Cell Patients with Leg Ulcers

To Test or Not to Test? Quantifying and Reducing Inappropriate Hypercoagulable Workups in the Inpatient Setting

Outcomes and Risk Factors Associated with Thrombosis Recurrence and Post-Thrombotic Syndrome in Children and Adolescents with May-Thurner Syndrome

Using Electronic Best Practice Alerts to Improve Thrombophilia Testing Based on ASH Choosing Wisely Guidelines

Referral for Thrombophilia Testing in an Obstetric Patient Population: A Tertiary Centre Experience

Use of Direct Oral Anticoagulants in Inherited Thrombophilia

Levels of Protein S and Risk of Thromboembolism

Efficacy of Direct Oral Anticoagulants (DOAC) in Patients with Antiphospholipid Antibody Syndrome (APS)

Final Results from the Phase 3 Traial Areta Comparing a Novel, Extended-Release Anagrelide Formulation to Placebo in Essential Thrombocythemia Patients with Defined Risk Status

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only